Table 2.
Descriptive statistics for all 26 patients
| Age (years) | 52.0 ± 12.2 (range 31–75) |
| Location | |
| Left | 17 |
| Right | 9 |
| MR | |
| a1 (cm) | 1.488 ± 0.255 (range 1.1–1.9) |
| b1 (cm) | 1.219 ± 0.325 (range 0.5–1.9) |
| ER positive | 23 |
| PR positive | 17 |
| HER2 positive | 6 |
| High expression of Ki67 | 13 |
| Molecular subtype | |
| Luminal A | 12 |
| Luminal B (HER2 negative) | 6 |
| Luminal B (HER2 positive) | 5 |
| HER2 enriched (nonluminal) | 1 |
| Triple negative | 2 |
Except for age and MR, the data are the number of patients
Luminal A: estrogen receptor (ER) and progesterone receptor (PR) positive, Ki67 level less than 20%, HER2 negative. Luminal B (HER2 negative): ER positive and HER2 negative (PR < 20% or Ki67 ≥ 20%). Luminal B (HER2 positive): ER and HER2 positive (PR < 20% or Ki67 ≥ 20%). HER2 enriched (nonluminal): ER and PR negative and HER2 positive. Triple negative: ER, PR, and HER2 negative